Structural Analysis of the Rhodopsin-Transducin Complex

视紫红质转导蛋白复合物的结构分析

基本信息

项目摘要

DESCRIPTION (provided by applicant): G-protein coupled receptors (GPCRs) are a large group of 7 transmembrane helix receptors that require ligand-dependent activation to initiate heterotrimeric (a, B, y) G-protein mediated intracellular signaling cascades. Due to their physiological relevance and pharmacological tractability, GPCRs are the focus of numerous drug discovery efforts. Activation of a G-protein by its agonist stimulated GPCR (R*) requires the propagation of structural signals from the receptor binding interface to the guanine nucleotide-binding pocket of the G-protein. The structural basis for the interaction of a GPCR with its cognate G-protein, and the subsequent activation of the G-protein by R*, are not fully understood. The overall goal of this research is to develop and apply high-resolution nuclear magnetic resonance (NMR) methods to probe the structural basis for the propagation of structural signals from R* to the G-protein, with a specific focus on elucidating structural changes in the a-subunit that lead to guanine nucleotide exchange. For these studies, signaling of the G-protein, transducin (Gt), by the light-activated GPCR, rhodopsin, will be used as a model system. The interaction of Gt with solubilized native and mutant rhodopsins, as well as soluble mimics of R*, will be employed to allow for the observation and trapping of discrete states accompanying signal transfer. Using isotope-labeled G-protein a-subunits, heteronuclear NMR methods will be used to selectively map structural changes in this subunit upon heterotrimer formation with unlabeled By-subunits and when trapped in discrete R* bound states. 3 fundamental structural questions surrounding the mechanism of R* mediated signal transfer will be addressed: 1. What structural changes in the receptor binding interface of the a-subunit occur upon interaction of the G-protein heterotrimer with R*?; 2. What are the structural changes in the guanine nucleotide binding site that occur upon interaction of the G-protein heterotrimer with R*?; 3. How are structural changes that result from the interaction of the binding interface of the a-subunit with R* correlated to changes in the conformation of the guanine nucleotide binding site? We expect that this work will have a fundamental impact on our understanding of the mechanisms governing activation of G-proteins by R* and form a basis for understanding the structural consequences of naturally occurring rhodopsin and Gt mutations associated with visual dysfunction.
描述(由申请人提供):G蛋白偶联受体(GPCR)是一大组7跨膜螺旋受体,需要配体依赖性激活以启动异源三聚体(a,B,y)G蛋白介导的细胞内信号级联。由于其生理相关性和药理学易处理性,GPCR是许多药物发现工作的焦点。G蛋白通过其激动剂刺激的GPCR(R*)的活化需要结构信号从受体结合界面传播到G蛋白的鸟嘌呤核苷酸结合口袋。GPCR与其同源G蛋白相互作用的结构基础以及随后通过R* 激活G蛋白的结构基础尚未完全理解。本研究的总体目标是开发和应用高分辨率核磁共振(NMR)方法来探测从R* 到G蛋白的结构信号传播的结构基础,特别关注阐明导致鸟嘌呤核苷酸交换的a亚基的结构变化。对于这些研究,将使用光激活的GPCR、视紫红质对G蛋白、转导素(Gt)的信号传导作为模型系统。Gt与溶解的天然和突变的视紫红质,以及R* 的可溶性模拟物的相互作用,将被用来允许观察和捕获伴随信号传递的离散状态。使用同位素标记的G-蛋白a-亚基,异源NMR方法将用于选择性地映射该亚基在与未标记的By-亚基形成异源三聚体时以及当被困在离散的R* 结合状态时的结构变化。围绕R* 介导的信号传递机制的3个基本结构问题将得到解决:1。当G蛋白异源三聚体与R* 相互作用时,a亚基的受体结合界面发生了什么结构变化?2. G蛋白异源三聚体与R* 相互作用时,鸟嘌呤核苷酸结合位点的结构发生了什么变化?3.由α-亚基与R* 的结合界面相互作用引起的结构变化如何与鸟嘌呤核苷酸结合位点的构象变化相关?我们希望这项工作将对我们理解R* 激活G蛋白的机制产生根本性影响,并为理解与视觉功能障碍相关的天然视紫红质和Gt突变的结构后果奠定基础。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

KEVIN Donald RIDGE其他文献

KEVIN Donald RIDGE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('KEVIN Donald RIDGE', 18)}}的其他基金

Structural Analysis of the Rhodopsin-Transducin Complex
视紫红质转导蛋白复合物的结构分析
  • 批准号:
    7248586
  • 财政年份:
    2006
  • 资助金额:
    $ 32.82万
  • 项目类别:
Structural Analysis of the Rhodopsin-Transducin Complex
视紫红质转导蛋白复合物的结构分析
  • 批准号:
    7096311
  • 财政年份:
    2006
  • 资助金额:
    $ 32.82万
  • 项目类别:
STRUCTURAL STUDIES OF G-PROTEIN COUPLED RECEPTORS
G 蛋白偶联受体的结构研究
  • 批准号:
    6708869
  • 财政年份:
    2001
  • 资助金额:
    $ 32.82万
  • 项目类别:
STRUCTURAL STUDIES OF G-PROTEIN COUPLED RECEPTORS
G 蛋白偶联受体的结构研究
  • 批准号:
    6628607
  • 财政年份:
    2001
  • 资助金额:
    $ 32.82万
  • 项目类别:
STRUCTURAL STUDIES OF G-PROTEIN COUPLED RECEPTORS
G 蛋白偶联受体的结构研究
  • 批准号:
    6498231
  • 财政年份:
    2001
  • 资助金额:
    $ 32.82万
  • 项目类别:
STRUCTURAL STUDIES OF G-PROTEIN COUPLED RECEPTORS
G 蛋白偶联受体的结构研究
  • 批准号:
    6879356
  • 财政年份:
    2001
  • 资助金额:
    $ 32.82万
  • 项目类别:
STRUCTURAL STUDIES OF G-PROTEIN COUPLED RECEPTORS
G 蛋白偶联受体的结构研究
  • 批准号:
    6233046
  • 财政年份:
    2001
  • 资助金额:
    $ 32.82万
  • 项目类别:
FOLDING AND ASSEMLY IN VISUAL RHODOPSIN
视觉视紫红质中的折叠和组装
  • 批准号:
    2711140
  • 财政年份:
    1996
  • 资助金额:
    $ 32.82万
  • 项目类别:
FOLDING AND ASSEMLY IN VISUAL RHODOPSIN
视觉视紫红质中的折叠和组装
  • 批准号:
    2165388
  • 财政年份:
    1996
  • 资助金额:
    $ 32.82万
  • 项目类别:
FOLDING AND ASSEMLY IN VISUAL RHODOPSIN
视觉视紫红质中的折叠和组装
  • 批准号:
    2888476
  • 财政年份:
    1996
  • 资助金额:
    $ 32.82万
  • 项目类别:

相似国自然基金

Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 批准年份:
    2020
  • 资助金额:
    24.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Novel PPAR-gamma agonist selectively activate the ligand binding domain of PPAR-gamma and improve pathology and memory deficits in a 3xTg-Ad mouse model.
新型 PPAR-gamma 激动剂选择性激活 PPAR-gamma 的配体结合域,改善 3xTg-Ad 小鼠模型的病理和记忆缺陷。
  • 批准号:
    8890576
  • 财政年份:
    2015
  • 资助金额:
    $ 32.82万
  • 项目类别:
Atomic force microscopy study of structural and functional changes in membrane proteins upon agonist and antagonist binding
激动剂和拮抗剂结合后膜蛋白结构和功能变化的原子力显微镜研究
  • 批准号:
    BB/M503113/1
  • 财政年份:
    2014
  • 资助金额:
    $ 32.82万
  • 项目类别:
    Training Grant
Agonist & Antagonist Activity and Binding on the TMD of hT1R3
激动剂
  • 批准号:
    7915254
  • 财政年份:
    2009
  • 资助金额:
    $ 32.82万
  • 项目类别:
Imaging Dopamine D2 Agonist Binding Sites in Cocaine Dependence with [11C]NPA
使用 [11C]NPA 对可卡因依赖中的多巴胺 D2 激动剂结合位点进行成像
  • 批准号:
    7782808
  • 财政年份:
    2009
  • 资助金额:
    $ 32.82万
  • 项目类别:
Imaging Dopamine D2 Agonist Binding Sites in Cocaine Dependence with [11C]NPA
使用 [11C]NPA 对可卡因依赖中的多巴胺 D2 激动剂结合位点进行成像
  • 批准号:
    7587737
  • 财政年份:
    2009
  • 资助金额:
    $ 32.82万
  • 项目类别:
Agonist & Antagonist Activity and Binding on the TMD of hT1R3
激动剂
  • 批准号:
    7725379
  • 财政年份:
    2009
  • 资助金额:
    $ 32.82万
  • 项目类别:
CONFORMATIONAL CHANGES AND MODE OF BINDING OF AGONIST TO ESTROGEN RECEPTOR
激动剂与雌激素受体的构象变化和结合方式
  • 批准号:
    7724014
  • 财政年份:
    2008
  • 资助金额:
    $ 32.82万
  • 项目类别:
Molecular determinants of melanocortin 4 receptor for selective agonist binding
黑皮质素 4 受体选择性激动剂结合的分子决定因素
  • 批准号:
    7669106
  • 财政年份:
    2008
  • 资助金额:
    $ 32.82万
  • 项目类别:
Agonist & Antagonist Activity and Binding on the TMD of hT1R3
激动剂
  • 批准号:
    7706667
  • 财政年份:
    2008
  • 资助金额:
    $ 32.82万
  • 项目类别:
Molecular recognition of barbiturate enantiomers in agonist binding site of nicotinic acetylcholine receptor
烟碱乙酰胆碱受体激动剂结合位点巴比妥酸盐对映体的分子识别
  • 批准号:
    19791062
  • 财政年份:
    2007
  • 资助金额:
    $ 32.82万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了